Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
31.6M
-
Number of holders
-
240
-
Total 13F shares, excl. options
-
37M
-
Shares change
-
+1.06M
-
Total reported value, excl. options
-
$1.29B
-
Value change
-
+$41.3M
-
Put/Call ratio
-
0.02
-
Number of buys
-
125
-
Number of sells
-
-110
-
Price
-
$34.99
Significant Holders of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) as of Q3 2025
266 filings reported holding COLL - COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share as of Q3 2025.
COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) has 240 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37M shares
.
Largest 10 shareholders include BlackRock, Inc. (5.18M shares), Rubric Capital Management LP (2.83M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.39M shares), VANGUARD GROUP INC (2.23M shares), RENAISSANCE TECHNOLOGIES LLC (1.6M shares), FULLER & THALER ASSET MANAGEMENT, INC. (1.5M shares), PRINCIPAL FINANCIAL GROUP INC (1.31M shares), STATE STREET CORP (1.29M shares), Invesco Ltd. (1.28M shares), and JANUS HENDERSON GROUP PLC (910K shares).
This table shows the top 240 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.